Six pharmaceutical companies have received approval from the Food and Drug Administration for the first generic versions of Eli Lilly’s Cymbalta, a prescription medication used to treat depression and other conditions. The FDA said Wednesday that it has cleared Aurobindo Pharma Ltd., Dr.
Procter & Gamble’s Align probiotic brand has kicked off its "Get Gutsy" challenge, aimed at helping give people the confidence to experience one of those "gutsy moments.
McKesson Pharmacy Systems and Automation (MPS&A) is launching a new EnterpriseRx Flexible Delivery solution that expands the reach of outpatient and retail pharmacies beyond their local communities.
The "sour then sweet" taste experience of Sour Patch Kids candy is being brought to Stride gum. Mondelez International Inc. said Tuesday that the new Stride Sour Patch Kids gum is slated hit store shelves next month and will come in Redberry and Lime flavors. Fans can have a first taste
Forest Laboratories Inc. has made a series of appointments to its executive leadership team as part of its effort to "flatten and broaden" its organization under a recently announced corporate streamlining plan.
STS Health has rolled out FluNada, a homeopathic throat and nasal spray for relief of cold and flu-like symptoms, to more than 5,000 retail pharmacies. The company said Monday that the over-the-counter cold/flu remedy, launched in January and previously sold through Amazon.
Hundreds of people joined executives from Markwins International and Walgreen Co. and singer Fergie to celebrate the companies’ presentation of $50,000 to fund AIDS research.
The Cardinal Health Foundation has awarded over $350,000 in grants to 29 nonprofit organizations that fight prescription drug abuse.
Chobani Inc. has named former Procter & Gamble Co. executive Dipak Golechha as its chief financial officer.
Coty Inc. has named Patrice de Talhouet as its new chief financial officer, starting early next year. The beauty care giant said Tuesday that de Talhouet will replace Sergio Pedreiro, who will stay on at Coty through March 2014 to provide a seamless transition.
The Biotechnology Industry Organization (BIO) has hired Patrick Plues as senior director of state government relations.
Forest Laboratories Holdings Ltd., a subsidiary of Forest Laboratories Inc., plans to buy the exclusive U.S. rights for Saphris sublingual tablets, a medication for schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a unit of Merck & Co.
Lannett Co. plans to transfer the listing of its common stock to the New York Stock Exchange (NYSE) from NYSE MKT. The generic pharmaceutical company said Monday that it expects its shares to begin trading on the NYSE as of Dec. 13 under its current ticker symbol, LCI. "This has been a tremendous
Cardinal Health Inc. has renewed its primary distribution agreement with pharmacy benefit manager Prime Therapeutics.
L’Oreal Group is forming a travel retail business unit to address the travel beauty care segment.
Merck has received approval from the Food and Drug Administration for Noxafil (posaconazole) 100-mg delayed-release tablets, an antifungal medication.
